Interleukin-6 (IL-6) is a cytokine, a signalling protein that immune cells, fat tissue, muscle and the liver use to coordinate inflammation. One reading does not diagnose anything. Read alongside related markers and repeated over months, it tells you whether your baseline inflammatory load is drifting up or down.
Interleukin-6 is a small signalling protein that cells release to coordinate the body's response to injury, infection and physical stress. It is produced by macrophages and T cells, by the cells lining blood vessels, by adipose tissue, and by skeletal muscle during contraction.
It works through two broad routes. In classic signalling, IL-6 binds a membrane receptor found mainly on liver cells and some immune cells, a pathway linked with tissue repair, defence and metabolic regulation. In trans-signalling, IL-6 binds a soluble version of its receptor and can then act on almost any cell in the body, and this route is the one most often associated with persistent, unresolved inflammation.
One of IL-6's main downstream jobs is telling the liver to produce acute-phase proteins, including C-reactive protein and fibrinogen. That is why these markers tend to move together, and why IL-6 sits upstream of the inflammation markers most people have seen on a standard report.
IL-6 is not purely an inflammatory signal. Research describes it as a metabolic hormone, with muscle-derived IL-6 rising sharply during exercise and influencing glucose uptake, fat breakdown and appetite signalling[1]. So the simple framing of high equals bad misses the point. A short spike after a hard session is normal physiology. A chronically raised resting level is the thing worth working on.
Related: Interleukin 6 Test Cost, What Changes the Price
A persistently raised IL-6 matters because it is one of the better-studied readouts of chronic low-grade inflammation, the slow background process associated with vascular, metabolic and age-related disease risk.
Research has examined IL-6 as a pathway and potential target in cardiovascular and cerebrovascular disease, where inflammatory signalling interacts with the arterial wall, clotting proteins and plaque stability[2]. The IL-6 family of cytokines has also been studied extensively in tumour biology, where it is described as part of the signalling environment around certain cancers[3].
These are associations and mechanistic findings, not a prediction about any individual. A raised IL-6 does not mean a disease is present, and a low IL-6 does not guarantee anything. What a tracked level gives you is direction. If your number is drifting upward year on year while your waist circumference, sleep and training are also drifting in the wrong direction, that pattern is informative in a way a single value never is.
IL-6 also tends to rise with age, a phenomenon often called inflammaging. That is part of why many optimization-minded readers want a baseline early, while there is time for habits to matter, rather than discovering a trend after a decade of drift.
Most laboratories report IL-6 against a reference range with an upper limit in the single digits, and optimization targets sit lower than that.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Interleukin-6 (IL-6), serum or plasma | 0 to 6 pg/mL | 0 to 2 pg/mL |
Reference ranges vary by laboratory, assay method, age and sex, so always read your result against the range printed on your own report. The optimal range shown is FitScript's optimization target, not a diagnostic cut-off, and nothing above or below it diagnoses a condition on its own.
Two practical points about reading the number. First, IL-6 has a short half-life and is released in pulses, so day-to-day and even hour-to-hour variation is real. A value near the top of the range on one draw may look different two weeks later with no change in health at all. Second, assay sensitivity differs between labs, so comparing an IL-6 result from one provider against a result from another is unreliable. If you want to track a trend, stay with the same laboratory and the same assay where possible.
The useful question is rarely whether a single value is inside or outside a range. It is whether repeated values, read next to other inflammatory and metabolic markers, are moving in the direction you want.
A raised IL-6 reflects that something, somewhere, is driving inflammatory signalling. It does not say what.
The most common and least alarming explanations are transient. A hard training session, a recent cold, a dental procedure, a new injury, a vaccination or a stretch of poor sleep can all lift the number for days. Acute infection raises it sharply, and IL-6 has been studied as a potential marker in sepsis, although the research describes it as promising rather than established[4].
Persistent elevation has a wider set of possible contributors. Chronic inflammatory and autoimmune conditions feature prominently in the literature, including psoriasis[5] and juvenile idiopathic arthritis[6], where IL-6 signalling is part of the disease mechanism. IL-6 has been studied in eye inflammation including noninfectious uveitis[7] and other retinal diseases[8], in Castleman disease, where it plays a central role[9], in melanoma biology[10], in schizophrenia research[11], and as a mediator in vasospasm after subarachnoid hemorrhage[12].
That list is not a menu of things you might have. It is context showing how broadly this one signal appears in medicine. For a general reader with no symptoms, the far more likely drivers are lifestyle and body composition.
The practical framing is observation, then possible meaning, then next step. Observation, your IL-6 is above the optimal range. Possible meaning, there may be an ongoing inflammatory stimulus, from body fat and poor sleep at the mild end to an active condition at the other. Next step, repeat the test when you are well and rested, look at it alongside related markers, and bring the pattern to a clinician rather than acting on one value.
A low or undetectable result is common and generally unremarkable. There is no established benefit to pushing IL-6 toward zero, and some IL-6 activity is part of normal repair and metabolic signalling.
In people without a diagnosed inflammatory condition, the usual drivers are a short and familiar list, and most of them are modifiable.
Visceral fat is near the top. Abdominal adipose tissue behaves like an endocrine organ, and the fat cells plus the immune cells embedded in them release inflammatory signals including IL-6 continuously. Insulin resistance travels with this and reinforces it.
Physical inactivity contributes independently of body weight. So does short or fragmented sleep, including untreated sleep-disordered breathing. Chronic psychological stress, smoking and vaping, and regular heavy alcohol intake are all associated with higher inflammatory signalling. Dietary pattern matters more than any single food, with diets low in fiber and high in ultra-processed foods and refined carbohydrate associated with higher markers.
Two often-missed contributors are worth naming. Oral health is one, since periodontal disease is a genuine chronic infection with systemic inflammatory consequences, and it is easy to ignore because it rarely hurts early. The second is under-recovery in athletic people. Heavy training volume without adequate sleep, food and rest days can keep inflammatory markers elevated in someone who looks, by every outward measure, extremely healthy.
Age is the one driver you cannot change. Inflammatory markers tend to creep upward across decades, which is exactly why the modifiable items earn more attention, not less, as you get older.
Reducing excess body fat, particularly visceral fat, is one of the most reliable ways to lower chronic inflammatory signalling, because the tissue itself is a source of IL-6.
Adipose tissue in a state of expansion recruits macrophages, and that immune cell population produces inflammatory cytokines locally that spill into circulation. Shrinking the tissue reduces the signal at the source.
The practical approach matters. A moderate energy deficit, adequate protein to protect lean mass, resistance training two or more times a week, and enough sleep to support recovery all point in the same direction. Very aggressive dieting is counterproductive here, since rapid loss with inadequate protein and sleep tends to raise stress hormones and cost muscle, and muscle is metabolically useful.
Waist circumference is a cheap proxy worth tracking alongside your labs. If the waist is coming down while training volume holds steady and sleep is intact, you have changed the input that matters most, and a repeat inflammatory panel some months later will usually reflect it.
If prescription weight-management therapy comes up in that conversation, a licensed provider evaluates whether any such treatment is appropriate for you, based on your full history, not on a biomarker alone.
Training lowers resting IL-6 even though each session raises it, because the acute muscle-derived release and the chronic inflammatory baseline are two different things.
During contraction, skeletal muscle releases IL-6 into the bloodstream, and the magnitude scales with duration and intensity. That release behaves more like a hormone than an alarm, influencing glucose availability, fat mobilization and signalling to other tissues[1]. It peaks around the end of exercise and falls back quickly. Repeated over months, regular training is associated with a lower resting inflammatory baseline, partly through fat loss, partly through improved insulin sensitivity, and partly through adaptations in the muscle itself.
Practically, public health physical activity guidance generally converges on roughly 150 minutes a week of moderate aerobic activity, or less time at higher intensity, plus at least two resistance sessions. Both components matter. Aerobic work drives the cardiometabolic adaptations, resistance work protects lean mass, which keeps the fat loss honest.
Three cautions. Do not train hard through an acute illness. Do not let training volume outrun your sleep and food, since under-recovery pushes markers the wrong way. And do not draw blood for IL-6 within a day or two of a hard or unusually long session, because the acute spike will contaminate the reading.
The eating patterns associated with lower inflammatory markers share a shape rather than a single ingredient, built on vegetables, fruit, legumes, whole grains, nuts, olive oil and fatty fish, with ultra-processed foods and refined sugar kept to the edges.
The proposed mechanisms are reasonable and mostly consistent. Dietary fiber feeds gut bacteria that produce short-chain fatty acids, which may support gut barrier integrity and have immune-modulating effects. Polyphenols from colourful plants, olive oil, tea, coffee and cocoa may influence inflammatory signalling pathways. Long-chain omega-3 fats from oily fish are precursors to specialized pro-resolving mediators, molecules thought to help switch inflammation off rather than simply blocking it. Lower glycemic load reduces post-meal glucose and insulin swings, which is relevant because insulin resistance and inflammation reinforce each other.
Dramatic language is not warranted here. Dietary changes generally shift inflammatory markers modestly, over months, and the size of the effect depends heavily on where you started. Someone moving from a largely ultra-processed diet to a whole-food pattern will see more than someone making a marginal tweak to an already good diet.
Two habits do most of the work for most people. Get fiber up toward the upper end of what is comfortable, from food rather than powders where possible. And reduce alcohol, which is both an inflammatory input and a sleep disruptor, a combination that works against you twice.
Sleep matters more than most people expect, and short or fragmented sleep is associated with higher inflammatory markers, including IL-6.
The mechanism is not mysterious. Sleep restriction raises sympathetic nervous system activity, disrupts normal cortisol rhythm, worsens next-day insulin sensitivity and increases appetite for energy-dense food. Each of those pushes inflammatory signalling upward. IL-6 also has a natural daily rhythm, which is one more reason to standardize the time of day you have blood drawn.
Untreated obstructive sleep apnea deserves a specific mention. Repeated overnight oxygen desaturation is a potent inflammatory stimulus, and it is common, underdiagnosed, and entirely treatable once identified. Loud snoring, witnessed pauses in breathing, morning headaches or heavy daytime sleepiness are all worth raising with a clinician, who can decide whether a sleep study is appropriate.
The practical fixes are unglamorous. A consistent sleep and wake time including weekends, morning daylight exposure, caffeine kept to the first half of the day, alcohol moved away from bedtime, and a cool, dark room. Regularity tends to matter as much as total hours, and it is the variable most people have the most control over.
Yes. Chronic psychological stress, regular heavy drinking and smoking or vaping are each associated with higher inflammatory signalling, and all three are modifiable.
Sustained stress keeps the sympathetic nervous system and the HPA axis active. Over time, immune cells may become less responsive to cortisol's normal restraining effect on inflammation, so the brake may work less well. That is the plausible route from a demanding year to a higher resting inflammatory baseline, and it is why stress is worth treating as a physiological input rather than a character question.
What appears to help is boring and repeatable. Regular aerobic exercise, strength training, time outdoors, genuine social contact, and a daily practice such as slow breathing or meditation. None of these will transform a lab value on their own, but together they change how much inflammatory load you carry into each week.
Alcohol shows a dose-dependent relationship with inflammatory markers, and heavy intake is clearly associated with higher levels. Smoking and vaping deliver a direct, repeated inflammatory and oxidative insult to the airway and vasculature, and cessation is one of the single highest-value changes available for anyone trying to bring these markers down. Dental care belongs in this section too, since treating gum disease removes a chronic infectious stimulus that otherwise runs quietly in the background for years.
Some supplements may have modest effects on inflammatory markers, but none of them substitute for sleep, training, body composition and diet, and none should be started without checking suitability with a clinician.
Long-chain omega-3 fatty acids from fish oil are the most studied, and they may modestly influence inflammatory markers, with effects depending on baseline intake and status. Curcumin from turmeric has been studied for inflammatory signalling, although absorption varies widely between preparations and any benefit is uncertain. Vitamin D is relevant mainly for people who are genuinely deficient, where correcting the deficiency is sensible on its own terms. Fiber supplements, probiotic and fermented foods are studied through their effect on the gut microbiome, a plausible but modest and still uncertain route.
Two honest caveats. First, a small change in a marker is not the same as a change in health outcomes. Second, interactions are real, and fish oil and certain botanicals matter if you take medication that affects blood clotting or are scheduled for surgery.
This page does not give amounts or schedules for any supplement or medication. What to take, whether to take anything at all, and how it fits with your other medications, are decisions for a licensed provider who can see your full history and your labs.
Interleukin-6 is measured in serum or plasma from a standard venous blood draw, using an immunoassay sensitive enough to detect concentrations in picograms per millilitre.
Because it is released in pulses, has a short half-life and follows a daily rhythm, timing and preparation affect the result more than they do for most routine markers. Four practical rules make the number worth reading. Draw in the morning, and keep the time consistent across repeat tests. Avoid testing within roughly 24 to 48 hours of hard or unusually long exercise. Postpone testing during an acute illness, after a vaccination, or soon after dental work or surgery, and wait until you have fully recovered. Use the same laboratory for repeat testing, since assays differ.
Fasting is not strictly required for IL-6 itself, but it is often drawn alongside glucose, insulin and lipids, so most people end up fasting anyway. Check the instructions that come with your requisition.
IL-6 is also rarely useful alone. FitScript's membership covers 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, and any treatment decision made by a licensed provider after reviewing the member. The value of that structure is that a single inflammatory reading is always read next to metabolic, hormonal and cardiovascular markers rather than in isolation.
IL-6 is most informative when read as part of an inflammatory and cardiometabolic picture, because each companion marker fills in something the others miss.
High-sensitivity C-reactive protein is the obvious partner, since the liver produces it largely in response to IL-6. CRP is more stable and cheaper, which makes it a better repeat-tracking marker, while IL-6 sits further upstream. Tumour necrosis factor alpha is another inflammatory cytokine often measured alongside, with its own drivers and its own variability. Fibrinogen is both an acute-phase protein and a clotting factor, so it links the inflammatory picture to vascular risk. Homocysteine reflects B-vitamin status and methylation and is studied in relation to vascular health, which makes it a reasonable companion rather than a direct inflammatory marker. Ferritin, ESR, HbA1c, fasting insulin and a full lipid panel including ApoB round out the picture.
Oxidized LDL is the marker readers most often ask about next. It estimates the fraction of LDL particles that have been chemically modified by oxidative damage, a process studied as part of how plaque forms in the arterial wall, and it connects the inflammation story to the lipid story. It is tested on a blood sample, usually fasting, using a specialized immunoassay. It is not part of a routine lipid panel, so it has to be requested specifically, either by a clinician ordering it individually or as part of an advanced cardiometabolic or inflammation panel. As with IL-6, a single oxidized LDL value is interpreted alongside ApoB, LDL particle count and inflammatory markers rather than on its own.
A realistic sequence is to establish a clean baseline, change the highest-yield inputs for a sustained block, then retest under the same conditions.
Step one, get a baseline worth trusting. Test when you are well, rested, and at least a day or two clear of hard training. Capture IL-6 alongside hs-CRP and the metabolic markers, and record your waist measurement, average sleep duration and weekly training volume on the same day.
Step two, rule out the loud drivers. Ask a clinician about anything obvious, untreated gum disease, suspected sleep apnea, a lingering infection, a known autoimmune condition, or a medication change. No amount of diet work compensates for an unaddressed inflammatory source.
Step three, fix sleep first. Set a consistent wake time, get morning light, move caffeine earlier and alcohol away from bedtime. It is the cheapest intervention and it makes every other change easier to sustain.
Step four, build the training floor. Aerobic work most days of the week plus two resistance sessions, with real rest days. Add volume slowly.
Step five, change the diet pattern, not the details. More fiber, more plants, more oily fish, olive oil and legumes. Fewer ultra-processed foods, less refined sugar, less alcohol. Keep protein adequate.
Step six, let body composition follow. A moderate deficit if there is excess visceral fat, tracked by waist and strength rather than scale weight alone.
Step seven, retest under the same conditions. Same lab, same time of day, same pre-test rules, after a few months of consistency. Then read the trend across markers with a clinician rather than reacting to one value.
It is worth contacting a clinician promptly when a raised inflammatory marker sits alongside symptoms, rather than appearing on its own in someone who feels well.
Symptoms that warrant a prompt conversation include unexplained fever, drenching night sweats, unintentional weight loss, persistent swollen or painful joints, a new rash, eye pain or vision change, severe or unexplained fatigue, or any marker that is substantially outside the standard laboratory range and stays there on a repeat test. Chest pain, breathlessness or neurological symptoms are urgent medical issues in their own right and should never wait for a lab result.
If you have a known inflammatory, autoimmune or cardiovascular condition, or you are on immunomodulating medication, interpretation belongs with the clinician managing that condition. Never ignore a result that is outside the standard range, and never stop or change a prescribed medication based on a biomarker you have read about. Where a prescription therapy is being considered, a licensed provider evaluates whether it is appropriate after reviewing your history, examination and full results.
For most readers, the honest answer is less dramatic. A mildly suboptimal IL-6 in someone who feels well is usually a prompt to look at sleep, waist circumference, training, alcohol and dental health, then retest. This article is educational and is not medical advice, and your results and any treatment should be discussed with a clinician or licensed provider who knows your history.
If you want to go deeper on the individual markers, the reference pages for Interleukin-6, c reactive protein, tnf alpha, fibrinogen and homocysteine explain what each one measures and how it is read, and the Advanced Inflammation panel shows which of them are typically tested together.
Oxidized LDL is measured on a blood sample, usually fasting, using a specialized immunoassay. It is not included in a routine lipid panel, so it must be requested specifically, either ordered individually by a clinician or included in an advanced cardiometabolic panel. Results are interpreted alongside ApoB, LDL particle count and inflammatory markers.
Expect months, not weeks. Sleep and alcohol changes can shift inflammatory signalling within weeks, while the larger gains from visceral fat loss and consistent training usually show up over roughly three months or more. Retest under the same conditions at the same lab so the comparison is meaningful rather than noise.
No. IL-6 is a cytokine released by immune cells, fat tissue and muscle, and it sits upstream. C-reactive protein is an acute-phase protein the liver produces largely in response to IL-6. CRP is cheaper and more stable for tracking trends, while IL-6 reflects the signal driving it.
A single raised value does not diagnose anything. Hard exercise, a recent infection, dental work, injury or poor sleep can all lift it temporarily. Repeat the test when well and rested, read it alongside other markers, and discuss any result that stays outside the standard range promptly with a clinician.
Fasting is not strictly required for IL-6 itself, but it is commonly drawn alongside glucose, insulin and lipids, which do require fasting. Follow the instructions on your requisition. Timing matters more here, draw in the morning, at a consistent time, and away from hard training or acute illness.
No. Regular training is associated with a lower resting inflammatory baseline over time, even though each session causes a temporary IL-6 spike from working muscle. What is worth reviewing is recovery, since heavy volume without adequate sleep and food can keep markers elevated. Avoid testing right after hard sessions.
Long-chain omega-3 fatty acids are the most studied and may have modest effects on inflammatory markers. Curcumin and correcting genuine vitamin D deficiency have some support, and fiber and fermented foods act through the gut microbiome. Amounts, suitability and interactions should be decided with a clinician or licensed provider.
A low or undetectable result is common and generally unremarkable, since assay sensitivity varies and IL-6 is released in pulses. Some IL-6 activity is part of normal tissue repair and metabolic signalling, so there is no established benefit to driving it toward zero. Focus on the trend rather than the floor.